Legal & General Group PLC Next Cure, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.6 - $10.28 $18,202 - $24,620	-2,395 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $1,579 - $2,234	-161 Reduced 6.3%	2,395 $24,000
Q3 2020 Nov 13, 2020	SELL	$8.15 - $21.17 $5,273 - $13,696	-647 Reduced 20.2%	2,556 $23,000
Q2 2020 Aug 14, 2020	BUY	$21.19 - $40.2 $18,265 - $34,652	862 Added 36.82%	3,203 $68,000
Q1 2020 May 14, 2020	SELL	$32.32 - $58.37 $17,646 - $31,870	-546 Reduced 18.91%	2,341 $86,000
Q4 2019 Feb 13, 2020	BUY	$25.0 - $92.22 $58,225 - $214,780	2,329 Added 417.38%	2,887 $155,000
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $7,901 - $11,517	558 New	558 $8,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $22.8M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.